Search Results - J. Gabriel Vasquez

Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis by Neal Bhatia, Jayme Heim, Brad Schenkel, J. Gabriel Vasquez

Connect to this object online.

Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting by Neal Bhatia, Jayme Heim, J. Gabriel Vasquez, Tina Bhutani, Brad Schenkel, Ranga Gogineni, John Koo

Connect to this object online.

Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis by Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J. Gabriel Vasquez

Connect to this object online.